11:50 AM EST - Emerald Health Therapeutics, Inc. : Has signed a letter of intent under which Sigma Analytical Services Inc., a full-service GMP-compliant testing laboratory for cannabis, hemp, and derived products, may acquire Emerald’s Avalite cannabis analytical testing operation. The companies also intend to establish a preferred partner relationship. Terms of the deal have been agreed to in principle and will be announced upon completion. Execution of definitive agreements is subject to due diligence and board approval of both companies and is expected to occur on or before April 19. Completion of the transaction will be subject to a number of conditions including settlement of final documentation and receipt of applicable regulatory and third-party approvals. Emerald Health Therapeutics, Inc.
shares V.EMH are trading down $0.025 at $0.19.
